Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/190002
Type 2 diabetes mellitus and COVID-19: a narrative review
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values in most high- and middle-income countries. T2DM could be a risk factor of developing complications in other diseases. Indeed, some studies suggest a bidirectional interaction between T2DM and COVID-19. A growing body of evidence shows that COVID-19 prognosis in individuals with T2DM is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with T2DM after SARS-CoV-2 infection. The most common treatments for T2DM may influence SARS-CoV-2 and their implication in infection is briefly discussed in this review. A better understanding of the link between TD2M and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients.
Matèries
Matèries (anglès)
Citació
Citació
REY REÑONES, Cristina, MARTINEZ TORRES, Sara, MARTÍN LUJÁN, Francisco m, PERICAS, Carles, REDONDO, Ana, VILAPLANA CARNERERO, Carles, DOMÍNGUEZ GARCÍA, Àngela, GRAU, Maria. Type 2 diabetes mellitus and COVID-19: a narrative review. _Biomedicines_. 2022. Vol. 10, núm. 2089. [consulta: 25 de febrer de 2026]. ISSN: 2227-9059. [Disponible a: https://hdl.handle.net/2445/190002]